Clinical Trial Update: Alendronate Prevents Microarchitectural Deterioration of Trabecular Bone in Early Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial results suggest that alendronate prevents microarchitectural deterioration of trabecular bone in early postmenopausal women with osteopenia or ost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Osteopenia, Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2011-08-10